Sign inJoin waitlistJoin the waitlist

Rajshekhar Chakraborty

Assistant Professor of Medicine · Columbia University Irving Medical Center

Credentials: · · · ·

History

Columbia University Irving Medical Center
Present

Cleveland Clinic
Icahn School of Medicine at Mount Sinai-Queens Hospital Center
University of Delhi

Research

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria
Leukemia · 2018 · 110 citations
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
Leukemia · 2017 · 106 citations
A systematic review of religious beliefs about major end-of-life issues in the five major world religions
Systematic review or meta-analysis · Palliative & Supportive Care · 2017 · First of 6 authors · 105 citations

Suzanne Lentzsch
45 papers
Morie Gertz
42 papers
Ghulam Mohyuddin
40 papers · 37 as a resident
Divaya Bhutani
34 papers
EM
Eli Muchtar
32 papers
Shaji Kumar
32 papers
Angela Dispenzieri
31 papers
Francis Buadi
26 papers
Prashant Kapoor
26 papers
David Dingli
24 papers
ML
Martha Lacy
24 papers
Suzanne Hayman
24 papers

Clinical trials

Teclistamab-Daratumumab in AL Amyloidosis
Principal investigator · Recruiting · Phase 2
Rajshekhar Chakraborty, MD
2025–2033
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Principal investigator · Active not recruiting · Phase 1, Phase 2
Columbia University
2022–2027
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2030
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2019–2029